Prenatal case report of Barth syndrome caused by novel TAFAZZIN mutation: Clinical characteristics of fetal dilated cardiomyopathy with ascites

Barth syndrome (BTHS) is a rare X-linked recessive genetic disease, which appears in infancy with myocardial and skeletal muscle diseases, neutropenia, growth retardation, and other clinical features. TAFAZZIN is the pathogenic gene of BTHS, which encodes the tafazzin protein of the inner membrane o...

Full description

Bibliographic Details
Main Authors: Xuliang Zhao, Xu Li, Weiwei Sun, Jian-an Jia, Min Yu, Ruixia Tian
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Pediatrics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2022.1004485/full
_version_ 1797984845834485760
author Xuliang Zhao
Xu Li
Weiwei Sun
Jian-an Jia
Min Yu
Ruixia Tian
author_facet Xuliang Zhao
Xu Li
Weiwei Sun
Jian-an Jia
Min Yu
Ruixia Tian
author_sort Xuliang Zhao
collection DOAJ
description Barth syndrome (BTHS) is a rare X-linked recessive genetic disease, which appears in infancy with myocardial and skeletal muscle diseases, neutropenia, growth retardation, and other clinical features. TAFAZZIN is the pathogenic gene of BTHS, which encodes the tafazzin protein of the inner membrane of the mitochondria, a phosphatidyltransferase involved in cardiolipin remodeling and functional maturation. At present, BTHS has been widely reported, but prenatal cases are rare. We report a 24+4-week fetus with clinical manifestations including left ventricular insufficiency and ascites. After induced labor, whole exome sequencing detection of fetal skin tissue showed that TAFAZZIN had the mutation c.311A > C/p.His104Pro and that his mother was the carrier. This His104Pro mutation has hitherto not been reported, and it is rated as likely to be pathogenic according to the American College of Medical Genetics and Genetics guidelines. Molecular dynamics and protein expression experiments on the His104Pro mutation showed that the stability of the local protein structure and protein expression were reduced. In conclusion, the case presented in this study enriches our knowledge of the TAFAZZIN mutation spectrum and suggests that His104Pro may lead to cardiac structural abnormalities in the early embryo. The possibility of BTHS should be considered when an abnormal cardiac structure or ascites appear in a prenatal ultrasound.
first_indexed 2024-04-11T07:08:13Z
format Article
id doaj.art-b98f5183ebdc4aa29da8d16d59314acd
institution Directory Open Access Journal
issn 2296-2360
language English
last_indexed 2024-04-11T07:08:13Z
publishDate 2022-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pediatrics
spelling doaj.art-b98f5183ebdc4aa29da8d16d59314acd2022-12-22T04:38:17ZengFrontiers Media S.A.Frontiers in Pediatrics2296-23602022-11-011010.3389/fped.2022.10044851004485Prenatal case report of Barth syndrome caused by novel TAFAZZIN mutation: Clinical characteristics of fetal dilated cardiomyopathy with ascitesXuliang Zhao0Xu Li1Weiwei Sun2Jian-an Jia3Min Yu4Ruixia Tian5Department of Laboratory, The 901th Hospital of the Joint Service of the People's Liberation Army, Hefei, ChinaDepartment of Radiology, Anhui Children's Hospital, Hefei, ChinaDepartment of Medical, Beijing Chigene Translational Medicine Research Center, Beijing, ChinaDepartment of Laboratory, The 901th Hospital of the Joint Service of the People's Liberation Army, Hefei, ChinaDepartment of Obstetrics and Gynecology, The 901th Hospital of the Joint Service of the People's Liberation Army, Hefei, ChinaDepartment of Obstetrics and Gynecology, The 901th Hospital of the Joint Service of the People's Liberation Army, Hefei, ChinaBarth syndrome (BTHS) is a rare X-linked recessive genetic disease, which appears in infancy with myocardial and skeletal muscle diseases, neutropenia, growth retardation, and other clinical features. TAFAZZIN is the pathogenic gene of BTHS, which encodes the tafazzin protein of the inner membrane of the mitochondria, a phosphatidyltransferase involved in cardiolipin remodeling and functional maturation. At present, BTHS has been widely reported, but prenatal cases are rare. We report a 24+4-week fetus with clinical manifestations including left ventricular insufficiency and ascites. After induced labor, whole exome sequencing detection of fetal skin tissue showed that TAFAZZIN had the mutation c.311A > C/p.His104Pro and that his mother was the carrier. This His104Pro mutation has hitherto not been reported, and it is rated as likely to be pathogenic according to the American College of Medical Genetics and Genetics guidelines. Molecular dynamics and protein expression experiments on the His104Pro mutation showed that the stability of the local protein structure and protein expression were reduced. In conclusion, the case presented in this study enriches our knowledge of the TAFAZZIN mutation spectrum and suggests that His104Pro may lead to cardiac structural abnormalities in the early embryo. The possibility of BTHS should be considered when an abnormal cardiac structure or ascites appear in a prenatal ultrasound.https://www.frontiersin.org/articles/10.3389/fped.2022.1004485/fulltafazzinprenatal diagnosisLVNCWEScongenital heart disease
spellingShingle Xuliang Zhao
Xu Li
Weiwei Sun
Jian-an Jia
Min Yu
Ruixia Tian
Prenatal case report of Barth syndrome caused by novel TAFAZZIN mutation: Clinical characteristics of fetal dilated cardiomyopathy with ascites
Frontiers in Pediatrics
tafazzin
prenatal diagnosis
LVNC
WES
congenital heart disease
title Prenatal case report of Barth syndrome caused by novel TAFAZZIN mutation: Clinical characteristics of fetal dilated cardiomyopathy with ascites
title_full Prenatal case report of Barth syndrome caused by novel TAFAZZIN mutation: Clinical characteristics of fetal dilated cardiomyopathy with ascites
title_fullStr Prenatal case report of Barth syndrome caused by novel TAFAZZIN mutation: Clinical characteristics of fetal dilated cardiomyopathy with ascites
title_full_unstemmed Prenatal case report of Barth syndrome caused by novel TAFAZZIN mutation: Clinical characteristics of fetal dilated cardiomyopathy with ascites
title_short Prenatal case report of Barth syndrome caused by novel TAFAZZIN mutation: Clinical characteristics of fetal dilated cardiomyopathy with ascites
title_sort prenatal case report of barth syndrome caused by novel tafazzin mutation clinical characteristics of fetal dilated cardiomyopathy with ascites
topic tafazzin
prenatal diagnosis
LVNC
WES
congenital heart disease
url https://www.frontiersin.org/articles/10.3389/fped.2022.1004485/full
work_keys_str_mv AT xuliangzhao prenatalcasereportofbarthsyndromecausedbynoveltafazzinmutationclinicalcharacteristicsoffetaldilatedcardiomyopathywithascites
AT xuli prenatalcasereportofbarthsyndromecausedbynoveltafazzinmutationclinicalcharacteristicsoffetaldilatedcardiomyopathywithascites
AT weiweisun prenatalcasereportofbarthsyndromecausedbynoveltafazzinmutationclinicalcharacteristicsoffetaldilatedcardiomyopathywithascites
AT jiananjia prenatalcasereportofbarthsyndromecausedbynoveltafazzinmutationclinicalcharacteristicsoffetaldilatedcardiomyopathywithascites
AT minyu prenatalcasereportofbarthsyndromecausedbynoveltafazzinmutationclinicalcharacteristicsoffetaldilatedcardiomyopathywithascites
AT ruixiatian prenatalcasereportofbarthsyndromecausedbynoveltafazzinmutationclinicalcharacteristicsoffetaldilatedcardiomyopathywithascites